Biocon enters Dow Jones Sustainability Index in Emerging Markets category

Pharma major makes it to the DJSI EM Index with a total sustainability score of 45 as against an industry average of 18

Biocon said on Wednesday that it has been selected for the Dow Jones Sustainability Index (DJSI) in the Emerging Markets (EM) category for its Environmental, Social and Governance (ESG) practices.

The pharma major made a formal submission for Corporate Sustainability Assessment for its listing on the DJSI  for the first time this year and made it to the DJSI EM Index with a total sustainability score of 45 as against an industry average of 18, achieving a 93rd percentile position.

It is among the top 15 companies from India and one of the 12 companies from the pharmaceuticals, biotechnology and life sciences sectors to be featured in the index for 2021. A total of 360 Indian companies were invited to participate in DJSI in 2021.

Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics, said, “Our business purpose is focused on delivering health equity by providing affordable access to life saving and essential medicines to patients across the world.”